Mice and humans with obesity and type 2 diabetes manifest ‘selective insulin resistance' in the liver: insulin fails to suppress gluconeogenesis, while it continues to activate lipogenesis, resulting in the combination of hyperglycaemia and steatosis15. This evidence concerns the gene INS and obesity disorder.